Detalhe da pesquisa
1.
FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease.
Nature
; 584(7822): 619-623, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32581359
2.
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries.
Ann Rheum Dis
; 82(6): 820-828, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36813538
3.
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial.
Ann Rheum Dis
; 82(10): 1286-1295, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37423647
4.
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset.
Ann Rheum Dis
; 81(8): 1085-1095, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470158
5.
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration.
Rheumatology (Oxford)
; 61(11): 4286-4296, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139178
6.
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response.
Rheumatology (Oxford)
; 61(9): 3799-3807, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34940840
7.
Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis.
Clin Exp Rheumatol
; 40(7): 1393-1402, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34796837
8.
Increased risk of inflammatory bowel disease among patients treated with rituximab in Iceland from 2001 to 2018.
Scand J Gastroenterol
; 56(1): 46-52, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33280485
9.
[Giant cell arteritis: a case report with scalp necrosis and sudden blindness].
Laeknabladid
; 107(12): 597-602, 2021 Dec.
Artigo
em Islandês
| MEDLINE | ID: mdl-34821576
10.
Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries.
Ann Rheum Dis
; 78(11): 1472-1479, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427438
11.
[Pregnancy outcomes in Icelandic female patients with inflammatory arthritides. Nationwide results from the ICEBIO and the Icelandic Medical Birth Register].
Laeknabladid
; 105(6): 267-275, 2019 06.
Artigo
em Islandês
| MEDLINE | ID: mdl-31192789
12.
Correction to: Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration.
Rheumatology (Oxford)
; 61(12): 4998, 2022 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35333334
13.
Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland.
Ann Rheum Dis
; 80(5): 671-672, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33402343
14.
Risk of drug-induced liver injury from tumor necrosis factor antagonists.
Clin Gastroenterol Hepatol
; 13(3): 602-8, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25131534
15.
Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO.
Rheumatology (Oxford)
; 53(11): 2100-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24939677
16.
Nationwide prevalence of glucocorticoid prescriptions over 17 years and osteoporosis prevention among long-term users.
SAGE Open Med
; 12: 20503121241235056, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38516640
17.
Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis.
Arthritis Res Ther
; 26(1): 61, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38444034
18.
Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial.
Arthritis Rheumatol
; 76(3): 363-376, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846618
19.
Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study.
RMD Open
; 10(2)2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38580350
20.
Patient-reported outcomes in axial spondyloarthritis and psoriatic arthritis patients treated with secukinumab for 24 months in daily clinical practice.
Semin Arthritis Rheum
; 65: 152388, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38301349